drugset / Trial / NCT02002611
Drug-drug Interaction Study(Lobeglitazone, Warfarin)
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate a pharmacokinetic drug interaction between lobeglitazone and warfarin in healthy subjects.
Timeline
- Start
- 2013-12
- Primary completion
- 2014-02
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lobeglitazone | Small molecule | 0.5 mg | — |
| Subject | Warfarin | Small molecule | 25 mg | — |